Other Royalty Provisions. Only one royalty will be due with respect to the same unit of Licensed Product, even if such Licensed Product unit is comprised of more than one Licensed Antibody or any modified or derivative forms thereof.
Appears in 3 contracts
Samples: Development and Option Agreement (Coherus BioSciences, Inc.), Development and Option Agreement (Surface Oncology, Inc.), Development and Option Agreement (Surface Oncology, Inc.)
Other Royalty Provisions. Only one royalty will be due with respect to the same unit of Licensed Product, even if such Licensed Product unit is comprised of more than one Licensed Antibody or any modified or derivative forms thereof. No royalties will accrue on the sale or other disposition of the Product by Alector or its Affiliates, licensees or sublicensees for use in a clinical study sponsored or funded by Alector or its Affiliates, licensees or sublicensees.
Appears in 1 contract
